Zeng H, Moise L, Grant MA, Hawrot E (June 2001). "The solution structure of the complex formed between alpha-bungarotoxin and an 18-mer cognate peptide derived from the alpha 1 subunit of the nicotinic acetylcholine receptor from Torpedo californica". The Journal of Biological Chemistry276 (25): 22930–40. PMID11312275. doi:10.1074/jbc.M102300200.
Love RA, Stroud RM (1986). "The crystal structure of alpha-bungarotoxin at 2.5 A resolution: relation to solution structure and binding to acetylcholine receptor". Protein Engineering1 (1): 37–46. PMID3507686. doi:10.1093/protein/1.1.37.
Chicheportiche R, Vincent JP, Kopeyan C, Schweitz H, Lazdunski M (May 1975). "Structure-function relationship in the binding of snake neurotoxins to the torpedo membrane receptor". Biochemistry14 (10): 2081–91. PMID1148159. doi:10.1021/bi00681a007.
Chen YH, Tai JC, Huang WJ, Lai MZ, Hung MC, Lai MD, Yang JT (May 1982). "Role of aromatic residues in the structure-function relationship of alpha-bungarotoxin". Biochemistry21 (11): 2592–600. PMID7093206. doi:10.1021/bi00540a003.
Zouridakis M, Giastas P, Zarkadas E, Chroni-Tzartou D, Bregestovski P, Tzartos SJ (November 2014). "Crystal structures of free and antagonist-bound states of human α9 nicotinic receptor extracellular domain". Nature Structural & Molecular Biology21 (11): 976–80. PMID25282151. doi:10.1038/nsmb.2900.
Vogel Z, Towbin M, Daniels MP (April 1979). "Alpha-bungarotoxin-horseradish peroxidase conjugate: preparation, properties and utilization for the histochemical detection of acetylcholine receptors". The Journal of Histochemistry and Cytochemistry27 (4): 846–51. PMID376692. doi:10.1177/27.4.376692.
Leopoldo M, Lacivita E, Berardi F, Perrone R (July 2009). "Developments in fluorescent probes for receptor research". Drug Discovery Today14 (13-14): 706–12. PMID19573791. doi:10.1016/j.drudis.2009.03.015.
nih.gov
ncbi.nlm.nih.gov
Zeng H, Moise L, Grant MA, Hawrot E (June 2001). "The solution structure of the complex formed between alpha-bungarotoxin and an 18-mer cognate peptide derived from the alpha 1 subunit of the nicotinic acetylcholine receptor from Torpedo californica". The Journal of Biological Chemistry276 (25): 22930–40. PMID11312275. doi:10.1074/jbc.M102300200.
Love RA, Stroud RM (1986). "The crystal structure of alpha-bungarotoxin at 2.5 A resolution: relation to solution structure and binding to acetylcholine receptor". Protein Engineering1 (1): 37–46. PMID3507686. doi:10.1093/protein/1.1.37.
Chicheportiche R, Vincent JP, Kopeyan C, Schweitz H, Lazdunski M (May 1975). "Structure-function relationship in the binding of snake neurotoxins to the torpedo membrane receptor". Biochemistry14 (10): 2081–91. PMID1148159. doi:10.1021/bi00681a007.
Chen YH, Tai JC, Huang WJ, Lai MZ, Hung MC, Lai MD, Yang JT (May 1982). "Role of aromatic residues in the structure-function relationship of alpha-bungarotoxin". Biochemistry21 (11): 2592–600. PMID7093206. doi:10.1021/bi00540a003.
Zouridakis M, Giastas P, Zarkadas E, Chroni-Tzartou D, Bregestovski P, Tzartos SJ (November 2014). "Crystal structures of free and antagonist-bound states of human α9 nicotinic receptor extracellular domain". Nature Structural & Molecular Biology21 (11): 976–80. PMID25282151. doi:10.1038/nsmb.2900.
Vogel Z, Towbin M, Daniels MP (April 1979). "Alpha-bungarotoxin-horseradish peroxidase conjugate: preparation, properties and utilization for the histochemical detection of acetylcholine receptors". The Journal of Histochemistry and Cytochemistry27 (4): 846–51. PMID376692. doi:10.1177/27.4.376692.
Leopoldo M, Lacivita E, Berardi F, Perrone R (July 2009). "Developments in fluorescent probes for receptor research". Drug Discovery Today14 (13-14): 706–12. PMID19573791. doi:10.1016/j.drudis.2009.03.015.